Bexarotene

Chemical formula: C₂₄H₂₈O₂  Molecular mass: 348.478 g/mol  PubChem compound: 82146

Therapeutic indications

Bexarotene is indicated for:

Cutaneous T-cell lymphoma (CTCL)

Population group: only adults (18 years old or older)

Bexarotene is indicated for the treatment of skin manifestations of advanced stage cutaneous T-cell lymphoma (CTCL) in adult patients refractory to at least one systemic treatment.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Bexarotene is contraindicated in the following cases:

Pancreatitis

Pancreatitis

Pregnancy

Pregnancy

Lactation

Lactation

Uncontrolled hypertriglyceridaemia

Hypertriglyceridaemia

Uncontrolled hypercholesterolaemia

Hypercholesterolemia

Hypervitaminosis A

Hypervitaminosis A

Uncontrolled thyroid disease

Disorder of thyroid gland

Hepatic insufficiency

Hepatic insufficiency

Ongoing systemic infection

Infectious disease

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: TARGRETIN Soft capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈